Patent ID: 7968571

Claim:
A compound of formula (I): wherein: X is Y 1 is N and Y 2 and Y 3 are each CH; A is selected from the group consisting of (1) hydrogen, (2) —C 1-10 alkyl, and (3) —C 2-10 alkenyl, wherein said alkyl or alkenyl is unsubstituted or substituted with one or more (a) halo, (b) —C 3-12 cycloalkyl, (c) —OH, (d) —CN, (e) —O—C 1-10 alkyl, (f) phenyl, or and said phenyl is unsubstituted or substituted with one or more (i) halo, (ii) —OH, (iii) —CN, (iv) —O—C 1-10 alkyl, (v) —C 1-10 alkyl, or (vi) —C 3-12 cycloalkyl; Q is —C 0-3 alkyl, wherein said alkyl is unsubstituted or substituted with one or more (1) halo, (2) —C 3-12 cycloalkyl, (3) —OH, (4) —CN, (5) —O—C 1-10 alkyl, and (6) —C 1-10 alkyl; R 1 is (1) aryl selected from the group consisting of phenyl and napthyl, (3) —C 1-10 alkyl, and (4) C 3-8 cycloalkyl, said cycloalkyl optionally fused to a C 6-10 aryl group, wherein said alkyl, cycloalkyl, or aryl is unsubstituted or substituted with one or more (a) halo, (b) —C 1-10 alkyl, wherein said alkyl is unsubstituted or substituted with halogen, (c) —OH, (d) —CN, (e) —O—C 1-10 alkyl, (f) —C 3-12 cycloalkyl, or (g) —NR 8 R 9 ; R 2 is selected from the group consisting of (1) —OH, and (2) —NR 8 R 9 , wherein R 8 and R 9 are selected from the group consisting of (a) hydrogen, (b) C 1-10 alkyl, and (c) C 0-6 alkyl-C 6-10 aryl, R 4 is selected from the group consisting of (1)—C 1-10 alkyl, or (2) —C 3-12 cycloalkyl, wherein said alkyl and cycloalkyl is unsubstituted or substituted with one or more (a) halo, (b) —OH, (c) —CN, (d) —O—C 1-10 alkyl, (e) —C 1-10 alkyl, (f) —C 3-12 cycloalkyl, (g) aryl selected from the group consisting of phenyl and napthyl, or and said aryl is unsubstituted or substituted with one or more (i) halo, (ii) —OH, (iii) —CN, (iv) —O—C 1-10 alkyl, (v) —C 3-12 cycloalkyl, or (vi) —C 1-10 alkyl; R 7 is selected from the group consisting of (1) hydrogen, (2) —C 1-10 alkyl, (3) aryl selected from the group consisting of phenyl and naphthyl; wherein said alkyl or aryl is unsubstituted or substituted with one or more (a) halo, (b) —OH, (c) —CN, (d) —O—C 1-10 alkyl, (e) —C 3-12 cycloalkyl, (f) aryl selected from the group consisting of phenyl and napthyl, or wherein said cycloalkyl, or aryl is unsubstituted or substituted with one or more (i) halo, (ii) —OH, (iii) —CN, (iv) —O—C 1-10 alkyl, (v) —C 3-12 cycloalkyl, or (vi) aryl selected from the group consisting of phenyl and napthyl; R 5 and R 6 are independently selected from the group consisting of (1) hydrogen, (2)—C 1-10 alkyl, (3) —C 2-10 alkenyl, (4) —C 2-10 alkynyl, and (5) —C 1-10 alkyl-C 3-12 cycloalkyl, wherein said alkyl, cycloalkyl, alkenyl or alkynyl is unsubstituted or substituted with one or more (a) halo, (b) —OH, (c) —CN, (d) —C 1-10 alkyl (e) —C 3-12 cycloalkyl, (f) —O—C 1-10 alkyl, (h) phenyl, or (i) —NR 8 R 9 ; and n is 0, 1, 2, 3 or 4; or a pharmaceutically acceptable salt thereof, or an individual enantiomer or diastereomer of said compound or said salt.